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Objective To examine whether the thickness of the sternocleidomastoid muscle (SCM) could be used as a 
prognostic factor for congenital muscular torticollis (CMT).
Method Th   is was a retrospective study conducted in a pediatric rehabilitation service at a tertiary medical center. 
Fifty-two children who met the following inclusion criteria were included: 1) children who were 3 month-old or 
younger, 2) children diagnosed with CMT, 3) passive rotation of the face toward the shoulder of the tilted side ≤60
o, 
4) children who had been managed according to the clinical pathway for CMT, 5) children who had been followed 
up for 6 months or more after the end of treatment. Th   e duration and total number of stretching exercise sessions 
were reviewed with reference to the thickness of the SCM. 
Results Among the 52 children with CMT, 46 children were successfully managed with only stretching exercise 
of the SCM for 1-6 weeks (group 1: 88.5%) and 6 children were managed with botulinum toxin A injection, 
surgical release or both in addition to stretching exercise (group 2: 11.5%). Th  e  diff  erence in the SCM thickness 
between the aff  ected and normal sides was signifi  cantly greater in group 2 than that in group 1 (p=0.026). A strong 
correlation was found between the total duration of stretching exercise and the diff  erence in the SCM thickness in 
group 1 (Pearson’ γ=0.429; p=0.003).
Conclusion Children with a thicker SCM seem to require a longer duration of stretching exercise and other 
therapeutic interventions in addition to stretching exercise for CMT. Th   erefore, the thickness of the SCM may be 
one prognostic factor for CMT treatment. 
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INTRODUCTION
  Congenital muscular torticollis (CMT) is the most 
common musculoskeletal disorder in infancy.
1 According 
to the diagnostic method and target population, the 
reported incidence of CMT varies from 0.0084-3.92% of 
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all newborns.
2-8 CMT occurs during or before the delivery, 
due to a shortened unilateral sternocleidomastoid 
muscle (SCM), and typically the head is tilted to the 
shortened muscle and at the same time the chin faces to 
the opposite direction.
1,4,9-12
  Th  e  fi  rst line treatment for CMT in neonates is physical 
therapy, including stretching exercise. Through 
stretching, >90% of the neonates reach full recovery 
without complications such as craniofacial deformation, 
but some groups do not reach full recovery even with an 
early suffi   cient period of stretching exercise.
1,13-15 Surgical 
treatment has traditionally been performed for these 
groups. The recent research on botulinum toxin type A 
injection has reported diff  erent results and eff  ects.
16-18
  Cheng et al.
13 reported that the average age of 510 
children when they were diagnosed with CMT was 24 
days (range: 10-299 days), and the age of symptom onset 
was one of the predictors of a response to a stretching 
exercise program. Yet few studies have investigated the 
prognostic factors of successful early stretching exercise 
for the CMT children diagnosed before the age of 3 
months.
19
  Ultrasonographic evaluation of CMT is the most widely 
employed method to obtain the primary diagnostic 
image, and making the diagnosis of CMT is possible by 
scanning and comparing the diff  erence in the thickness 
of the SCMs of infants. 
  Our clinical experience led us to hypothesize about the 
prognosis of CMT, that is, if the thickness of the SCM, as 
evaluated by ultrasonography, was a prognostic factor 
for successful stretching exercise, then this could help 
clinicians make the diagnosis, as well as guide the course 
of treatment. If the shortened SCM is thicker than the 
criteria at the time of diagnosis, then we could predict 
that stretching exercise alone would not cause complete 
recovery. Although patients do recover with stretching 
exercise only, perhaps we can predict that the thicker 
the SCM is, the longer the required period of stretching 
exercise. This can be very useful predictive information 
for both the clinician and patients.
  The objective of this study was to investigate whether 
the thickness of the SCM, as examined by ultrasound, is a 
prognostic factor for the management of early-diagnosed 
CMT (before 3 months of age). 
MATERIALS AND METHODS
Subjects
  Th   e subjects in this study were infants who were treated 
for abnormal posturing of the head and neck in the 
Center for Torticollis at the Department of Physical 
Medicine and Rehabilitation from 2003 to 2006. Among 
the 246 children who were treated, the inclusion 
criteria were 1) children with CMT, 2) age >3 months 
at presentation, 3) neck passive rotation was at least 
60 degree to the mass side in the relaxed position, 4) 
subjects were treated according to the clinical pathway 
(Fig. 1), and had been followed up for >6 months at the 
end of treatment. Th   e exclusion criteria were 1) children 
with CMT and who had previous manual stretching 
exercise done before they came to our clinic, 2) children 
with neurodevelopmental conditions that could cause 
a delay of head control, and 3) children with any 
infl  ammatory and/or infectious diseases of the neck. 
  The diagnosis of CMT was made when the following 
criteria were simultaneously met: 1) the head was tilted 
toward the shoulder of one side and the chin was turned 
toward the shoulder of the opposite side, and 2) the SCM 
muscle of the involved side was >2 mm thicker than that 
of the non-tilted side as shown on ultrasonography.
Treatment of CMT
  The children were treated according to our clinical 
pathway for CMT (Fig. 1). As first-line therapy, all the 
children diagnosed before 3 months were treated with 
manual stretching exercise for the shortened SCM by 
therapists as an outpatient 3-5 days per week. Each 
session of physical therapy consisted of passive rotation, 
lateral flexion of the neck to stretch the shortened 
SCM, therapeutic ultrasound for the shortened SCM, 
and massage for the mass for 20 to 30 minutes a day 
by physical therapists with >10 years experience. In 
addition to manual stretching exercise by a therapist, a 
caregiver was taught stretching exercise, and this person 
was encouraged to give one or two sessions of manual 
stretching exercise at home per day. 
  When there was no definite resistance during the 
rotation of the face, and it could be rotated to 90 degrees 
to the mass side, and simultaneously there was no 
resistance during lateral flexion of the face to the non-
mass side as compared with that of the other side, the The Thickness of the SCM as a Prognostic Factor for CMT
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management was considered successful and it was 
terminated regardless of the presence of the neck mass 
of CMT. If the head tilt was left in the coronal plane, but 
rotation and flexion of the neck on passive motion had 
no limit, then we judged that the tilted head was not due 
to a shortened SCM and we ended treatment.
  Despite of stretching for up to 4-6 weeks, if there were 
limitations of neck fl  exion and rotation, and a signifi  cant 
reduction in the SCM muscle mass thickness was not 
observed, we thought the head asymmetry was likely 
to progress, and the patient was treated as follows: 1) 
Type A botulinum toxin was injected into the shortened 
SCM, 2) surgical release for the shortened SCM, and 
3) Type A botulinum toxin injection and surgical 
release. Botulinum toxin type A (BOTOX
®, Allergan Inc., 
California, USA) mixed with 0.9% saline and diluted to a 
total of 2 cc (2-4 units/kg) was injected into the muscle 
mass using 27-gauge and 30 mm needles and a 1 cc 
syringe. If surgery was necessary, from 6 months of age, 
the shortened SCM was released by the third author of 
this study. A transverse 1.5 cm skin incision was made 1 
cm above and between the sternal and clavicular ends of 
the SCM. The contracted fibrous tissue and contracted 
myofascia were released and the sternal end, clavicular 
end, or both ends were released on a case by case basis 
using bipolar electrocautery.
  Therefore, by the clinical pathway, the children whose 
treatment was terminated after only stretching exercise 
(group 1) were treated during a different period of time 
within 6 weeks of terminating the stretching exercise, 
depending on the child’s reaction. Group 2 is shown 
in (Fig. 1). After completing the stretching exercise-III 
Fig. 1. Clinical pathway for treatment of children with congenital muscular torticollis.Jae Deok Han, et al.
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without recovery and choosing the patients who received 
an injection of botulinum toxin type A, stretching exercise 
by the therapist was made optional after the injection. 
If the children did not recover, the shortened SCM was 
released after 6 months of age. Clinical pathway B: If the 
patient did not recover by stretching exercise III, and 
there was sustained resistance after 3 additional weeks of 
stretching exercise by the therapist, the shortened SCM 
was released after 6 months of age. Therefore, the total 
duration and number of sessions of stretching by the 
therapist was quantifi  ed in group 1, but not in group 2. 
Measurement of the SCM thickness
  On the ultrasonography performed at presentation, the 
thickness of the SCM was measured at the thickest point 
of the SCM on both sides on the longitudinal view of 
ultrasonography. Th  e  diff  erences of thickness of the SCMs 
were compared between the two groups: the patients 
who successfully ended treatment only with stretching 
exercise within 6 weeks (group 1), and the patients for 
whom stretching exercise alone did not end treatment, so 
botulinum toxin type A injection and/or surgical release 
was done in addition to stretching exercise (group 2). 
Th  e  diff  erence of thickness was calculated from the data 
of the measured right and left SCMs, and the ratio of 
the thickness of the SCMs was defined as the thickness 
of the shortened SCM/contralateral SCM thickness. In 
addition, the duration of stretching exercise and the total 
number of sessions of stretching exercise were reviewed. 
Th   en, the relationships between the mass thickness, the 
duration of stretching, and the total number of treatment 
sessions were analyzed.
Statistical analysis
  SPSS 11.5 for Windows was used for all the statistical 
analyses in this study. Independent t-tests were used 
to compare the thickness of the SCMs between group 
1 and group 2. Correlation analysis with Pearson’s γ 
correlation coefficient was used for group 1 to evaluate 
the relationship between the difference of thickness 
between the SCMs and the duration of stretching 
exercise. A predictive linear regression model was 
constructed through linear regression analysis for group 
1 to determine the treatment outcome. The level for 
significance for all the statistical analyses was set at 
p=0.05.
RESULTS
Comparison between group 1 and group 2 (Table 1, 2)
  Fifty-two children (32 boys and 20 girls, age at 
presentation: 1.14±0.66 month-old, range: 13 day-old 
Table 1. Comparison of Group 1 and Group 2
Variables
Mean±SD (range)
p-value
Group 1 (n=46) Group 2 (n=6)
Age at presentation (days) 32.4±17.1 (13-90) 47.7±33.3 (16-90) 0.319
Side-to-side SCM muscle thickness diff  erence (mm)      6.6±2.2 (2.6-10.3)      8.8±2.0 (6.8-12.5) 0.026
Th   e ratio of the SCMs 2.33±0.53 (1.48-3.70) 2.77±0.72 (2.23-4.21) 0.730
Side-to-side SCM muscle thickness ratio: the thickness of the shortened SCM/the thickness of the contralateral SCM
Table 2. Characteristics of the Subjects of Group 2 (n=6)
Subject
Gender/Age (months) 
at the fi  rst visit
Th  erapeutic  methods
Subject 1        F/0.6
Stretching exercises + botulinum toxin A injection Subject 2  M/1
Subject 3   F/1
Subject 4   F/3 Stretching exercises + surgical release
Subject 5 M/1 Stretching exercises + botulinum toxin A injection
 + surgical release Subject 6 M/3The Thickness of the SCM as a Prognostic Factor for CMT
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−3 month-old) were included in this study. Among the 
52 children with CMT, 46 children (group I: 88.5%) were 
successfully managed with only stretching exercise of 
the SCM muscle for <6 weeks, and they did not show 
recurrence through 6 months of follow-up.
  Among the 52, 6 children (group 2: 11.5%) were 
managed with botulinum toxin A injection and/or 
surgical release in addition to stretching exercise, and the 
normal neck range of motion was recovered (Table 2). 
Th  e  diff  erence of thickness between the SCMs (p=0.026, 
6.6±2.2 mm in group 1, and 8.8±2.0 mm in group 2) was 
signifi  cantly greater in group 2 than in group 1 (Table 1; 
p<0.05). Among the 52 children, the normal side of SCM 
thickness was 5.21±0.80 mm, so if the thickness of the 
mass side SCM was larger (>8.8 mm) than the normal 
side, or the shortened SCM thickness was >14.01 mm 
(5.21+8.8 mm), then treatment other than stretching 
exercise was required. However, there were no signifi  cant 
differences between group 1 and group 2 for the age of 
presentation and the ratio of the SCM thickness (Table 1, 
p>0.05).
Correlation analysis and linear regression analysis of 
the total duration of stretching exercise and the SCM 
thickness diﬀ  erence in group 1 (Table 3, Fig. 2) 
  Group A included 46 patients who recovered with only 
stretching exercise and they were treated for a total 
of 19.76±15.33 days, and with 11.54±8.59 sessions of 
stretching exercise. The correlation analysis performed 
for these factors showed that the total period of stretching 
exercises (Pearson γ correlation coefficient: 0.429, 
p=0.003) and the total number of stretching exercises 
(Pearson γ correlation coefficient: 0.404, p=0.005) 
showed significant correlation with the differences in 
the thickness of the SCM. Also, the SCM thickness ratio 
showed signifi  cant correlation with the total duration of 
the stretching exercises (Pearson γ correlation coeffi   cient: 
0.427, p=0.003), and the total number of relaxation 
exercise sessions (Pearson γ correlation coefficient: 
0.403, p=0.005). Therefore, in group 1 (patients who 
recovered with only stretching exercise), results showed 
that the larger the size of the mass, the longer the period 
of treatment and the greater the number of treatment 
sessions (Table 3). However, the age at presentation had 
no signifi  cant correlation with the duration of stretching 
exercise and the total number of treatment sessions (Table 
3, p>0.05). Correlation analysis showed more signifi  cant 
correlation between the duration of stretching exercises 
and the diff  erence of thickness between the SCMs (0.429 
of Pearson γ correlation coeffi   cient: 0.429, p=0.003, Table 
3). Th   e linear regression analysis (Fig. 2) of the duration 
of stretching exercise for CMT with the difference of 
thickness between the SCMs (DIFF) in group I showed 
the following equation with an adjusted R
2 of 0.166 
(p=0.003): Th   e duration of stretching exercises for CMT= 
-0.487+3.051 (DIFF).
Table 3. Intercorrelations for the Stretching Exercise Parameters and the Patient Variables in Group 1 (n=46)
Stretching exercise 
parameters
SCM diff  erence SCM ratio Age at presentation
Total duration 0.429* 0.427* −0.108
‡
Total number  0.404
† 0.403
† −0.085
‡
SCM diff  erence: Side-to-side SCM muscle thickness diff  erence, SCM ratio: Side-to-side SCM muscle thickness ratio
*p=.003 for Pearson’s γ correlation coeffi   cient, 
†p=.005, 
‡p>0.05
Fig. 2. Regression analysis of the duration of stretching 
exercise and the side-to-side sternocleidomastoid (SCM) 
muscle thickness difference (DIFF) in group 1. Duration of 
stretching exercises for CMT (DUR in days)=-0.487+3.051 
(DIFF in mm) with an adjusted R
2 of 0.166 (p=0.003).Jae Deok Han, et al.
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DISCUSSION
  This study revealed that a thicker SCM on the tilted 
side seemed to require a longer duration of stretching 
exercise and other therapeutic interventions in addition 
to stretching exercise for children with CMT and who 
were diagnosed before 3 months of age.
  Lim et al.
19 recently reported that children with CMT 
required >12 months of stretching exercise and their 
ultrasonographic thickness ratio of the SCMs (shortened 
SCM thickness/normal SCM thickness) was 3.38 (range: 
2.45 to 4.31). Th   e children with CMT required <12 months 
of stretching exercise, their ultrasonographic thickness 
ratio was 2.04 (range: 1.14 to 2.94), and the results of this 
current study were in agreement with Lim et al.’s results. 
However, in that previous study, they did not comment 
about a necessity for other treatments, such as surgical 
release, besides stretching exercise. Ultrasonography is 
the most common modality used to diagnose CMT, and 
is also used for the follow-up to judge the eff  ectiveness of 
stretching exercise.
2,20-24
  Cheng et al.
20 reported that for children with CMT, when 
diagnosed by ultrasonography, the ratio of the upper 1/3 
and lower 1/3 of the shortened SCM thickness over the 
normal side was correlated with the degree of cervical 
rotation restriction. Accordingly, those authors addressed 
the relation between the SCM thickness and the severity 
of symptoms at the time of diagnosis, but they did not 
mention the correlation with stretching exercise as a 
prognostic factor.
  In this study, for the children with CMT with an age at 
the time of diagnosis of <3 months, the thickness of the 
SCM could be the prognostic factor for the management 
of CMT. It is well known that the majority of children 
with CMT are brought for management before the age 
of 3 months
13 Further studies are warranted to compare 
the prognosis of children with CMT and whose age is >3 
month-old, with that of children with CMT and whose 
age is <3 months.
  Stretching exercise of the shortened SCM is known as the 
first-line management for CMT, yet chemodenervation 
by using botulinum toxin and surgical release can be 
used for the recalcitrant cases.
16,17 To the best of our 
knowledge, there is no proposed therapeutic guideline 
for CMT using manual stretching exercise, botulinum 
toxin A injection, and surgery. Therefore, we had to 
develop our own clinical pathway (Fig. 1) for the children 
with CMT who were 3 month-old or younger. Our study 
with this clinical pathway showed that 88.5% of the 
children were successfully treated with only manual 
stretching exercises, with a mean duration of 19.86 days. 
Th   e remaining children (11.5%) needed other therapeutic 
options such as botulinum toxin A injection, and/or 
surgical release even after manual stretching exercise for 
up to 3-5 weeks.
  Celayir
25 reported the treatment outcome of 45 children 
with CMT whose mean age was 38.6 days (range: 15-
120 days) old at initial assessment. All the children were 
successfully treated with an intensive home treatment 
protocol of passive stretching exercises, with a mean 
treatment duration of 3.2 months. Th   ese results involved 
a relatively longer term of stretching exercise to produce 
complete recovery, as compared to that of our study.
  This current study revealed a relatively higher rate of 
botulinum toxin A injection±surgical release (11.5%) 
than that of the reports by Celayir
25 and Cheng et al.,
13 
and this result could be related to the relatively short 
duration of manual stretching exercise (up to a little 
less than 6 weeks). There is some dispute regarding the 
proper timing for performing surgical release of the SCM 
in children with CMT.
10,26-28
  Cheng et al. recommended that surgical treatment 
should be considered when a patient underwent at least 
6 months of controlled manual stretching and the patient 
still had residual head tilt, defi  cits of passive rotation and 
lateral bending of the neck >15
o, and a tight muscular 
band or tumor.
22 However, as children get older, they 
get more strength in their body including the neck, and 
their waking hours during the day get longer. Once a 
child reaches the milestones of head control and rolling-
over, (-age of 3-4 months), implementation of manual 
stretching exercises is not always easy to accomplish 
because of the child’s physical and emotional resistance.
  Moreover, Yu et al.
29 recommended surgical release 
before 1 year of age to prevent and reverse any cranial 
deformity because this deformity appears on the cranium 
and cranial base during early life. We performed surgical 
release at 6 months of age for CMT children who did not 
show a significant reduction of thickness of the SCM, 
and who still had moderate limitation of the cervical 
rotation range and craniofacial asymmetry after 6 weeks 
of stretching exercise.
  Botulinum toxin injection was performed for the 
patients who still had a considerably shortened SCM The Thickness of the SCM as a Prognostic Factor for CMT
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despite of receiving stretching exercise. Injected 
botulinum toxin causes the SCM to paralyze, making the 
SCM easier to be stretched, and it lessens the size of the 
muscle mass. 
  Oleszek et al.
17 reported that they used botulinum toxin 
type A in the treatment of children with CMT and who 
failed to improve their range of motion with stretching 
exercise. A total of 27 children who were 10.1 months 
of age (range: 6-18 months of age) received botulinum 
toxin type A injections into only their SCM (29.7 units), 
their trapezius muscle (28.3 units), or both (55 units). 
Seventy-four percent of the children had improved 
cervical rotation or head tilt after the injections and 7% of 
the children experienced transient adverse events (mild 
dysphagia and neck weakness).
  Collins and Jankovic
16 reported that they injected 150 
units of botulinum toxin type A into the SCM of children 
who were 8 months of age, but the eff  ect was negligible, 
and they also reported that only 2 out of 6 adults with 
CMT and who were injected with botulinum toxin type A 
showed improvement. Because of the reported negative 
results of botulinum toxin injection for adult patients 
with CMT, research on the safety of injecting botulinum 
toxin into infants is needed.
  In this study, if neck motion limitation was not 
observed after stretching exercise, then the treatment 
was discontinued. Clinically, we observed that as a child 
grew, the mass size lessened, so we considered that the 
stretching exercise did not directly have an effect on 
lessening the mass size. 
  The ultrasonographic-assessed disappearance of the 
mass was reported to be delayed by an average of 2 
weeks as compared to the clinical disappearance of the 
mass,
30 and it is known that the normal muscle volume 
was increased at the periphery, and muscle fibers were 
regenerated within the mass with the decrease in fi  brosis 
of CMT.
30,31
  This study was a retrospective study with several 
limitations. We had a small number of patients and 
we did not include other potential prognostic factors 
of CMT, such as ultrasonographic information like the 
echogenicity. Furthermore, the linear regression analysis 
of the duration of stretching exercises for CMT with the 
diff  erence of thickness between the SCMs showed a R
2 of 
0.166, indicating the relatively low power of the model. 
Therefore, further studies on other potential prognostic 
factors of CMT are required in addition to the thickness 
of SCM. 
  In spite of these limitations, we believe that this report 
shows the direct relationship between the thickness of 
the SCM and the prognosis of CMT, and we suggest that 
if the thickness of the mass-side SCM is larger by 8.8 mm 
as compared to the normal side, or the shortened SCM 
thickness is >14.01 mm, the prognosis for the stretching 
exercise is poor. In addition, in the previous studies with 
an older age group, the researchers generally used the 
ratio of the diff  erent SCMs rather than depth diff  erence as 
an indicator of CMT. In this study, the age was restricted 
to <3 months, which is a narrow age range. Th  erefore,  the 
diff  erence of thickness of the SCMs as well as the ratio of 
the diff  erent SCMs could be used as an eff  ective indicator 
for the prognosis of this age group.
CONCLUSION
  Children with a thicker SCM of the tilted side seem 
to require a longer duration of stretching exercise and 
other therapeutic interventions, in addition to stretching 
exercise for CMT, which indicates that the thickness of 
the SCM seems to be one of the prognostic factors of 
CMT.
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